Davide Andrea Coppini (Davide A Coppini)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Pluripotent Stem Cells

Walled Carbon Nanotubes

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Eleonora Colombo, Davide Andrea Coppini, Simone Borsoi, Valerio Fasano, Raffaella Bucci, Francesca Bonato, Elisa Bonandi, Francesca Vasile, Stefano Pieraccini, Daniele Passarella
Total Synthesis of an Epothilone Analogue Based on the Amide-Triazole Bioisosterism. ChemPlusChem (2024)
Eleonora Colombo, Davide Andrea Coppini, Simone Maculan, Pierfausto Seneci, Benedetta Santini, Filippo Testa, Lucia Salvioni, Giovanni Maria Vanacore, Miriam Colombo, Daniele Passarella
Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles. RSC advances 12 (54) (2022)
Eleonora Colombo, Davide Andrea Coppini, Laura Polito, Umberto Ciriello, Giuseppe Paladino, Mariafrancesca Hyeraci, Maria Luisa Di Paolo, Giulia Nordio, Lisa Dalla Via, Daniele Passarella
Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles. Molecules (Basel, Switzerland) 28 (1) (2022)
Eleonora Colombo, Davide Andrea Coppini, Laura Polito, Umberto Ciriello, Giuseppe Paladino, Mariafrancesca Hyeraci, Maria Luisa Di Paolo, Giulia Nordio, Lisa Dalla Via, Daniele Passarella
Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles. Molecules (Basel, Switzerland) 28 (1) (2022)
Eleonora Colombo, Davide Andrea Coppini, Laura Polito, Umberto Ciriello, Giuseppe Paladino, Mariafrancesca Hyeraci, Maria Luisa Di Paolo, Giulia Nordio, Lisa Dalla Via, Daniele Passarella
Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles. Molecules (Basel, Switzerland) 28 (1) (2022)
Eleonora Colombo, Davide Andrea Coppini, Simone Maculan, Pierfausto Seneci, Benedetta Santini, Filippo Testa, Lucia Salvioni, Giovanni Maria Vanacore, Miriam Colombo, Daniele Passarella
Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles. RSC advances 12 (54) (2022)